Suchergebnisse - "Tabarsi, Payam"

PubPharm (363)

31

Pulmonary tuberculosis and rhinosinus mucormycosis co-infection in a diabetic patient

enthalten in: Current medical mycology | 2022

von Shabani, S. | Tabarsi, P. | Afzal, G.

32

Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Salehi, M. | Hosseini, H. | Jamshidi, H. | +9

33

Delayed post-pneumonectomy empyema necessitans caused by Aspergillus flavus : An unusual report

enthalten in: Respirology case reports | 2022

von Hakamifard, A. | Gharedaghi, B. | Tabarsi, P. | +4

34

Extracellular Vesicles from Serum of Mycobacteria Patients Accelerate Expression of Apoptosis miRNAs and Facilitate THP-1 Monocyte Cell Death

enthalten in: Tanaffos | 2022

von Javadi, A. | Shamaei, M. | Tabarsi, P. | +2

35

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran : findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults

enthalten in: BMJ open | 2022

von Mohraz, M. | Salehi, M. | Tabarsi, P. | +13

ErratumIn: BMJ Open. 2022 Nov 7;12(11):e056872corr1. - PMID 36344009

36

Evaluation of Lymphocyte Subtypes in COVID-19 Patients

enthalten in: Tanaffos | 2022

von Rezaei, M. | Marjani, M. | Tabarsi, P. | +11

37

Mixed etiology COVID-19 associated acute rhinosinusitis caused by two Aspergillus species

enthalten in: Annals of medicine and surgery (2012) | 2022

von Tabarsi, P. | Sharifynia, S. | Pourabdollah Toutkaboni, M. | +4

38

Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD) : a case series

enthalten in: Annals of clinical microbiology and antimicrobials | 2022

von Mahdaviani, S. | Fallahi, M. | Jamee, M. | +10

39

Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series

enthalten in: Annals of clinical microbiology and antimicrobials | 2022

von Mahdaviani, S. | Fallahi, M. | Jamee, M. | +10

40

Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series

enthalten in: Annals of clinical microbiology and antimicrobials | 2022

von Mahdaviani, S. | Fallahi, M. | Jamee, M. | +10